Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy

This study has been completed.
Sponsor:
Information provided by:
R-Pharm
ClinicalTrials.gov Identifier:
NCT00035516
First received: May 3, 2002
Last updated: February 9, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2004
  Primary Completion Date: April 2004 (Final data collection date for primary outcome measure)